Ophthalmology · San Antonio, TX
NPI
1508070525
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1100 N Main Ave
San Antonio, TX, 78212
Phone (210) 222-2154
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
20,560 services
Medicare patients, 2024
1,107
Average age 76
Drug cost, 2024
$1.4M
8,628 prescriptions
Company payments, 2025
$1,452
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Oday J Alsheikh was code 83861 (clinical chemistry), 3,333 times for 775 patients. In total Oday J Alsheikh billed 20,560 services in 77 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83861 Clinical Chemistry | Office | 3,333 | 775 | $21.95 | $73K |
| 92012 Ophthalmological E&M | Office | 2,697 | 819 | $62.92 | $170K |
| 0507T Imaging - Miscellaneous | Office | 2,132 | 830 | $15.48 | $33K |
| 92285 Standard X-ray | Office | 1,513 | 685 | $13.92 | $21K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,319 | 878 | $26.72 | $35K |
| 92083 Vision, Hearing, and Speech Services | Office | 824 | 572 | $44.50 | $37K |
| 92202 Ophthalmological E&M | Office | 624 | 594 | $11.07 | $6,905 |
| 92020 Ophthalmological E&M | Office | 615 | 573 | $20.39 | $13K |
| 92014 Ophthalmological E&M | Office | 575 | 556 | $85.80 | $49K |
| 92133 Computerized Ophthalmic Imaging | Office | 533 | 494 | $23.82 | $13K |
| 92250 Angiography | Office | 476 | 401 | $24.84 | $12K |
| 67028 Intravitreal Injection | Office | 341 | 55 | $85.55 | $29K |
| 92071 Ophthalmological E&M | Office | 311 | 65 | $34.72 | $11K |
| 92136 Ultrasound - Nonspecific | Office | 295 | 213 | $27.21 | $8,026 |
| 99204 Office E&M - New | Office | 265 | 265 | $109.14 | $29K |
By year: 2022 $946K for 18,959 services; 2023 $1.1M for 20,979 services; 2024 $1.2M for 20,560 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 3,333 | 775 | $21.95 | $73K |
Medicare prescription drug claims, 2024
In 2024, the drug Oday J Alsheikh prescribed most often to Medicare patients was Ofloxacin, with 1,542 prescriptions and refills. In total Oday J Alsheikh wrote 8,628 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofloxacin Generic | 1,542 | 1,636 | 739 | $21K |
| Prednisolone Acetate Generic | 905 | 1,030 | 508 | $35K |
| Latanoprost Generic | 652 | 1,373 | 202 | $6,637 |
| Flurbiprofen Sodium Generic | 548 | 553 | 204 | $14K |
| Fluorometholone Generic | 543 | 655 | 251 | $43K |
| Erythromycin Erythromycin Base | 381 | 415 | 162 | $4,246 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 370 | 737 | 108 | $5,720 |
| Timolol Maleate Generic | 367 | 718 | 127 | $5,665 |
| Bromfenac Sodium Generic | 275 | 305 | 150 | $43K |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 250 | 468 | 60 | $41K |
| Restasis Cyclosporine | 247 | 442 | 93 | $260K |
| Tafluprost Tafluprost/Pf | 203 | 287 | 33 | $33K |
| Prolensa Bromfenac Sodium | 201 | 228 | 107 | $71K |
| Brimonidine Tartrate Generic | 186 | 334 | 60 | $27K |
| Cyclosporine Generic | 156 | 351 | 70 | $102K |
Brand drugs: - claims; generic drugs: 5,630 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Oday J Alsheikh $1,452 ($1,452 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $458.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 9 | $458 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 4 | $165 |
| Mallinckrodt Hospital Products Inc. | 9 | $159 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $118 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $110 |
| Glaukos Corporation GKOS | 1 | $100 |
| Carl Zeiss Meditec USA, Inc. | 1 | $68.73 |
| LENSAR, Inc. LNSR | 1 | $68.29 |
| Thea Pharma Inc. | 3 | $56.96 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $50.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.